Please login to the form below

Not currently logged in
Email:
Password:

CNS

This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.

Avanir’s week goes from bad to worse with Alzheimer’s stumble

Avanir’s week goes from bad to worse with Alzheimer’s stumble

Otsuka paid $3.5bn to  acquire Avanir in 2014 as part of a strategy to expand its presence in the central nervous system (CNS) disease category in the US.

Latest news

More from news
Approximately 5 fully matching, plus 172 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest from PMHub

  • Diagnosing the lag in neuropsychiatric treatments

    Unlike the other organs in our body, the central nervous system (CNS) is surrounded by the Blood Brain Barrier (BBB). ... To say the BBB presents a formidable challenge in CNS drug development is an understatement.

  • Innovative approaches in the treatment of multiple sclerosis

    Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In the central nervous system (CNS, which includes the brain, optic nerves and spinal cord),

  • Innovative approaches in the treatment of multiple sclerosis

    Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In the central nervous system (CNS, which includes the brain, optic nerves and spinal cord),

  • Shionogi Ltd. appoints Star for UK launch

    Their pipeline focuses on infectious disease, pain, CNS and oncology. Star were chosen as preferred partner on the basis of the company’s ability to provide the very best talent to

  • A fast-growing client services team at emotive.

    Starting his career in Medical Education and then moving into healthcare advertising, Andy has worked on large global brands in CNS, infectious diseases, respiratory and rare diseases. ... Also with a Biomedical Science degree, Sabrina worked in

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics